The loudness dependence of the auditory evoked potential (LDAEP) as a predictor of the response to escitalopram in patients with generalized anxiety disorder

Psychopharmacology

Volumn 213, Issue 2-3, 2011, Pages 625-632

  Park, Young Min ^a,b   Kim, Do Won ^b,c   Kim, Sangrae ^b,d   Im, Chang Hwan ^c   Lee, Seung Hwan ^a,b  

^a Inje University   (South Korea)

^b Clinical Emotion and Cognition Research Laboratory   (South Korea)

^c Yonsei University Wonju   (South Korea)

^d Yonsei University   (South Korea)

Author keywords

Current source density; Generalized anxiety disorder; LDAEP; Serotonin; sLORETA

Indexed keywords

ESCITALOPRAM;

ADULT; ARTICLE; BECK ANXIETY INVENTORY; CLINICAL ARTICLE; CLINICAL GLOBAL IMPRESSION SCALE; CONTROLLED STUDY; DRUG DOSE INCREASE; EVOKED AUDITORY RESPONSE; FEMALE; GENERALIZED ANXIETY DISORDER; HAMILTON ANXIETY SCALE; HUMAN; LOUDNESS; LOW RESOLUTION BRAIN ELECTROMAGNETIC TOMOGRAPHY; MALE; PREDICTION; PRIORITY JOURNAL; TREATMENT OUTCOME;

ADULT; AGED; ANXIETY DISORDERS; CITALOPRAM; ELECTROMAGNETIC PHENOMENA; EVOKED POTENTIALS, AUDITORY; FEMALE; HUMANS; LINEAR MODELS; LOUDNESS PERCEPTION; MALE; MIDDLE AGED; PSYCHIATRIC STATUS RATING SCALES; SEROTONIN UPTAKE INHIBITORS; SEVERITY OF ILLNESS INDEX; TOMOGRAPHY; TREATMENT OUTCOME;

EID: 79952486656     PISSN: 00333158     EISSN: 14322072     Source Type: Journal    
DOI: 10.1007/s00213-010-2061-y     Document Type: Article

References (40)

1. American Psychiatric Association (1994) Diagnostic and Statistical Manual of Mental Disorders, DSM-IV, 4th edn. American Psychiatric Press, Washington, DC
2. Bandelow B, Zohar J, Hollander E, Kasper S, Möller HJ, WFSBP task force on treatment guidelines for anxiety, obsessive-compulsive and post-traumatic stress disorders (2008) World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the pharmacological treatment of anxiety, obsessive-compulsive and post-traumatic stress disorders - first revision. World J Biol Psychiatry 9:248-312
3. Brett M, Johnsrude IS, Owen AM (2002) The problem of functional localization in the human brain. Nat Rev Neurosci 3:243-249 (Pubitemid 135706594)
4. Connor KM, Davidson JR (1998) Generalized anxiety disorder: neurobiological and pharmacotherapeutic perspectives. Biol Psychiatry 44:1286-1294 (Pubitemid 29015866)
5. Coric V, Stock EG, Pultz J, Marcus R, Sheehan DV (2009) Sheehan suicidality tracking scale (Sheehan-STS): preliminary results from a multicenter clinical trial in generalized anxiety disorder. Psychiatry (Edgmont) 6:26-31
6. Davidson JR (2009) First-line pharmacotherapy approaches for generalized anxiety disorder. J Clin Psychiatry 70:25-31
7. Fuchs M, Kastner J, Wagner M, Hawes S, Ebersole JS (2002) A standardized boundary element method volume conductor model. Clin Neurophysiol 113:702-712 (Pubitemid 34439274)
8. Gallinat J, Bottlender R, Juckel G, Munke-Puchner A, Stotz G, Kuss HJ, Mavrogiorgou P, Hegerl U (2000) The loudness dependency of the auditory evoked N1/P2-component as a predictor of the acute SSRI response in depression. Psychopharmacology (Berl) 148:404-411 (Pubitemid 30169759)
9. Garvey MJ, Noyes R Jr, Woodman C, Laukes C (1995) Relationship of generalized anxiety symptoms to urinary 5-hydroxyindoleacetic acid and vanillylmandelic acid. Psychiatry Res 57:1-5
10. Germine M, Goddard AW, Woods SW, Charney DS, Heninger GR (1992) Anger and anxiety responses to m-chlorophenylpiperazine in generalized anxiety disorder. Biol Psychiatry 32:457-461
11. Gorwood P (2004) Generalized anxiety disorder and major depressive disorder comorbidity: an example of genetic pleiotropy? Eur Psychiatry 19:27-33
12. Gudlowski Y, Ozgürdal S, Witthaus H, Gallinat J, Hauser M, Winter C, Uhl I, Heinz A, Juckel G (2009) Serotonergic dysfunction in the prodromal, first-episode and chronic course of schizophrenia as assessed by the loudness dependence of auditory evoked activity. Schizophr Res 109:141-147
13. Guille V, Croft RJ, O'Neill BV, Illic S, Phan KL, Nathan PJ (2008) An examination of acute changes in serotonergic neurotransmission using the loudness dependence measure of auditory cortex evoked activity: effects of citalopram, escitalopram and sertraline. Hum Psychopharmacol 23:231-241 (Pubitemid 351577693)
14. Handley SL (1995) 5-HT pathways in anxiety and its treatment. Pharmacol Ther 66:103-148
15. Hegerl U, Juckel G (1993) Intensity dependence of auditory evoked potentials as an indicator of central serotonergic neurotransmission: a new hypothesis. Biol Psychiatry 33:173-187 (Pubitemid 23089966)
16. Hegerl U, Gallinat J, Juckel G (2001) Event-related potentials. Do they reflect central serotonergic neurotransmission and do they predict clinical response to serotonin agonists? J Affect Disord 62:93-100
17. Hettema JM (2008) What is the genetic relationship between anxiety and depression? Am J Med Genet C Semin Med Genet 148C:140-146
18. Iny LJ, Pecknold J, Suranyi-Cadotte BE, Bernier B, Luthe L, Nair NP, Meaney MJ (1994) Studies of a neurochemical link between depression, anxiety, and stress from [3H]imipramine and [3H] paroxetine binding on human platelets. Biol Psychiatry 36:281-291 (Pubitemid 24288757)
19. Juckel G, Molnár M, Hegerl U, Csépe V, Karmos G (1997) Auditory-evoked potentials as indicator of brain serotonergic activity - first evidence in behaving cats. Biol Psychiatry 41:1181-1195 (Pubitemid 27237179)
20. Juckel G, Hegerl U, Molnár M, Csépe V, Karmos G (1999) Auditory evoked potentials reflect serotonergic neuronal activity - a study in behaving cats administered drugs acting on 5-HT1A autoreceptors in the dorsal raphe nucleus. Neuropsychopharmacology 21:710-716
21. Juckel G, Gallinat J, Riedel M, Sokullu S, Schulz C, Möller HJ, Müller N, Hegerl U (2003) Serotonergic dysfunction in schizophrenia assessed by the loudness dependence measure of primary auditory cortex evoked activity. Schizophr Res 64:115-124 (Pubitemid 37412333)
22. Juckel G, Pogarell O, Augustin H, Mulert C, Müller-Siecheneder F, Frodl T, Mavrogiorgou P, Hegerl U (2007) Differential prediction of first clinical response to serotonergic and noradrenergic antidepressants using the loudness dependence of auditory evoked potentials in patients with major depressive disorder. J Clin Psychiatry 68:1206-1212 (Pubitemid 47395622)
23. Juckel G, Hegerl U, Giegling I, Mavrogiorgou P, Wutzler A, Schuhmacher C, Uhl I, Brüne M, Mulert C, Pogarell O, Rujescu D (2008) Association of 5-HT1B receptor polymorphisms with the loudness dependence of auditory evoked potentials in a community-based sample of healthy volunteers. Am J Med Genet B Neuropsychiatr Genet 147B:454-458 (Pubitemid 351830802)
24. Kendler KS, Gardner CO, Gatz M, Pedersen NL (2007) The sources of co-morbidity between major depression and generalized anxiety disorder in a Swedish national twin sample. Psychol Med 37:453-462
25. Linka T, Müller BW, Bender S, Sartory G (2004) The intensity dependence of the auditory evoked N1 component as a predictor of response to Citalopram treatment in patients with major depression. Neurosci Lett 367:375-378 (Pubitemid 39178616)
26. Linka T, Sartory G, Bender S, Gastpar M, Müller BW (2007) The intensity dependence of auditory ERP components in unmedicated patients with major depression and healthy controls. An analysis of group differences. J Affect Disord 103:139-145 (Pubitemid 47445765)
27. Manjarrez G, Hernandez E, Robles A, Hernandez J (2005) N1/P2 component of auditory evoked potential reflect changes of the brain serotonin biosynthesis in rats. Nutr Neurosci 8:213-218 (Pubitemid 43250399)
28. Mulert C, Juckel G, Augustin H, Hegerl U (2002) Comparison between the analysis of the loudness dependency of the auditory N1/P2 component with LORETA and dipole source analysis in the prediction of treatment response to the selective serotonin reuptake inhibitor citalopram in major depression. Clin Neurophysiol 113:1566-1572 (Pubitemid 35283943)
29. Nathan PJ, Segrave R, Phan KL, O'Neill B, Croft RJ (2006) Direct evidence that acutely enhancing serotonin with the selective serotonin reuptake inhibitor citalopram modulates the loudness dependence of the auditory evoked potential (LDAEP) marker of central serotonin function. Hum Psychopharmacol 21:47-52 (Pubitemid 43192475)
30. Paige SR, Fitzpatrick DF, Kline JP, Balogh SE, Hendricks SE (1994) Event-related potential amplitude/intensity slopes predict response to antidepressants. Neuropsychobiology 30:197-201 (Pubitemid 24350939)
31. Paige SR, Hendricks SE, Fitzpatrick DF, Balogh S, Burke WJ (1995) Amplitude/intensity functions of auditory event-related potentials predict responsiveness to bupropion in major depressive disorder. Psychopharmacol Bull 31:243-248
32. Park YM, Lee SH, Kim S, Bae SM (2010) The loudness dependence of the auditory evoked potential (LDAEP) in schizophrenia, bipolar disorder, major depressive disorder, anxiety disorder, and healthy controls. Prog Neuropsychopharmacol Biol Psychiatry 34:313-316
33. Pascual-Marqui RD (2002) Standardized low resolution brain electromagnetic tomography (sLORETA): technical details. Methods Find Exp Clin Pharmacol 24:5-12
34. Ramboz S, Oosting R, Amara DA, Kung HF, Blier P, Mendelsohn M, Mann JJ, Brunner D, Hen R (1998) Serotonin receptor 1A knockout: an animal model of anxiety-related disorder. Proc Natl Acad Sci USA 95:14476-14481 (Pubitemid 28549392)
35. Semlitsch HV, Anderer P, Schuster P, Presslich O (1986) A solution for reliable and valid reduction of ocular artifacts, applied to the P300 ERP. Psychophysiology 23:695-703 (Pubitemid 17014356)
36. Senkowski D, Linden M, Zubrägel D, Bär T, Gallinat J (2003) Evidence for disturbed cortical signal processing and altered serotonergic neurotransmission in generalized anxiety disorder. Biol Psychiatry 53:304-314 (Pubitemid 36175544)
37. Sramek JJ, Tansman M, Suri A, Hornig-Rohan M, Amsterdam JD, Stahl SM, Weisler RH, Cutler NR (1996) Efficacy of buspirone in generalized anxiety disorder with coexisting mild depressive symptoms. J Clin Psychiatry 57:287-291 (Pubitemid 26251107)
38. Strobel A, Debener S, Schmidt D, Hünnerkopf R, Lesch KP, Brocke B (2003) Allelic variation in serotonin transporter function associated with the intensity dependence of the auditory evoked potential. Am J Med Genet B Neuropsychiatr Genet 118B:41-47 (Pubitemid 37064074)
39. Taylor DP, Eison MS, Riblet LA, Vandermaelen CP (1985) Pharmacological and clinical effects of buspirone. Pharmacol Biochem Behav 23:687-694 (Pubitemid 16191768)
40. You JS, Hu SY, Chen B, Zhang HG (2005) Serotonin transporter and tryptophan hydroxylase gene polymorphisms in Chinese patients with generalized anxiety disorder. Psychiatr Genet 15:7-11 (Pubitemid 40411564)